japan

Press Release: Sanofi and Regenerons Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on…

2 weeks ago

Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved…

2 weeks ago

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million…

4 weeks ago

Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

November 14, 2025 17:05 ET  | Source: Waldencast plc NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:…

2 months ago

Srixon Celebrates Another LPGA Victory as Nasa Hataoka Triumphs at TOTO Japan Classic

HUNTINGTON BEACH, Calif., Nov. 9, 2025 – Srixon staffer Nasa Hataoka is back in the winner’s circle after capturing the…

2 months ago

Kia Marks Japan Debut with PBV PV5′ at Japan Mobility Show 2025

Kia enters the Japanese market with the PV5, targeting the fast-growing EV van demand driven by Japan’s carbon neutrality goals,…

2 months ago

Lamborghini Day Japan 2025 ignites Tokyo with the Asia Pacific debut of the Fenomeno and an exclusive Ad Personam Revuelto

Where performance meets passion in Japan — an extraordinary celebration of Lamborghini’s iconic supercars, powered by a spectacular parade of…

2 months ago

ALVAREZ & MARSAL LAUNCHES IN JAPAN WITH HIRING OF SIX MANAGING DIRECTORS TO STEER SERVICE SUITE OFFERING

Firm opens offices in Tokyo and Osaka as demand grows for differentiated consulting services TOKYO and OSAKA, Japan, Oct. 16, 2025…

3 months ago

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of64Cu-PSMA-I&T for Prostate Cancer in Japan

PARIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Curium Group announced today that together with PeptiDream Inc. and PDRadiopharma Inc., a…

3 months ago

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan

BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.  (NASDAQ: LNTH) and GE HealthCare…

3 months ago